Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Royal North Shore Hospital, Sydney, Australia.
Lymphat Res Biol. 2022 Jun;20(3):248-259. doi: 10.1089/lrb.2021.0050. Epub 2021 Nov 8.
The impact of conservative interventions on lymphatic function and the relationship to clinical outcomes is currently unknown. A systematic review was undertaken to evaluate studies that used lymphoscintigraphy to measure outcomes from conservative intervention for secondary arm lymphedema and to explore the relationship between changes in the lymphoscintigraphy and clinical outcomes. Five databases were systematically searched using the selection criteria: randomized controlled trials (RCTs); quasi-RCTs; pre/post and cohort studies; upper limb secondary lymphedema; use of lymphoscintigraphy as an outcome measure; and conservative intervention. Seven articles met the inclusion criteria. Compression, exercise, hyperbaric oxygen therapy, and pharmacological interventions were evaluated using lymphoscintigraphy. There was heterogeneity with all aspects of the lymphoscintigraphy techniques, including radioisotope used, injection location, use of exercise, and imaging sequence between the studies as well as the outcome analysis. Also most studies did not show a relationship between the clinical and lymphoscintigraphy outcomes measured. Lymphoscintigraphy has not been used regularly or recently to evaluate conservative upper limb lymphedema treatment outcomes. Lack of standardization of lymphoscintigraphy protocols and lack of consensus and understanding of the lymphoscintigraphy analyses used to measure the outcomes of diverse conservative lymphedema interventions currently limit the use of lymphoscintigraphy as an outcome measure. Further research adopting recent guidelines to standardize lymphoscintigraphy and use of reliable analysis techniques that measure the physiological impact of the chosen conservative lymphedema intervention is recommended to evaluate the impact of conservative interventions on lymphatic function.
保守治疗对淋巴功能的影响及其与临床结果的关系目前尚不清楚。本系统评价旨在评估使用淋巴闪烁显像术来衡量继发性上肢淋巴水肿保守治疗结果的研究,并探讨淋巴闪烁显像术变化与临床结果之间的关系。采用以下选择标准对 5 个数据库进行系统检索:随机对照试验(RCT);准 RCT;前后对照研究和队列研究;上肢继发性淋巴水肿;淋巴闪烁显像术作为结局测量指标;以及保守干预。有 7 篇文章符合纳入标准。使用淋巴闪烁显像术评估了压缩、运动、高压氧治疗和药物干预。由于各方面的原因,包括使用的放射性同位素、注射部位、运动的使用以及成像序列,所有研究之间存在异质性,且对淋巴闪烁显像术结果的分析也存在异质性,此外,大多数研究并未显示出临床和淋巴闪烁显像术结果之间的关系。淋巴闪烁显像术尚未被常规或近期用于评估保守性上肢淋巴水肿治疗结果。淋巴闪烁显像术方案缺乏标准化,并且缺乏对用于衡量各种保守性淋巴水肿干预措施结局的淋巴闪烁显像术分析的共识和理解,目前限制了淋巴闪烁显像术作为结局测量指标的应用。建议采用最近的指南来标准化淋巴闪烁显像术,并使用可靠的分析技术来测量所选保守性淋巴水肿干预措施的生理影响,以评估保守性干预对淋巴功能的影响。